 |
||
|
|
Hypertension Diagnostics Securities to Be Listed on OTC Bulletin Board
ST. PAUL, MN – March 17,
2003 – Hypertension Diagnostics, Inc. (Nasdaq SmallCap: HDII),
today announced that it has requested a withdrawal from The Nasdaq
SmallCap Market effective as of the open of the markets on March 21, 2003
so that its securities may be listed on the OTC Bulletin Board. The
Company’s common stock and Redeemable Class B Warrant will be eligible for
immediate quotation on the OTC Bulletin Board after withdrawal from The
Nasdaq SmallCap Market. The symbol for the Company’s common stock is
expected to remain “HDII” and the Company’s Redeemable Class B Warrant is
expected to remain “HDIIZ.” The Company’s request for withdrawal from The
Nasdaq SmallCap Market was made concurrently with the Company’s
notification to the Nasdaq Listing Qualifications Hearings Department that
the Company would not continue its appeal of the Nasdaq Staff
Determination that the Company’s securities be delisted from The Nasdaq
SmallCap Market. |
|
|
Forward-looking statements in this press release are made under the safe
harbor provisions of the Private Securities Litigation Reform Act of 1995.
The Company wishes to caution readers not to place undue reliance on any
forward-looking statements and to recognize that the statements are not a
prediction of actual future results. Actual results could differ
materially from those presented and anticipated in the forward-looking
statements due to the risks and uncertainties set forth in the Company’s
2002 Annual Report on Form 10-KSB under the caption “Risk Factors,” as
well as others not now anticipated. Return
to the Main HDI Newsroom
|
||
|
Copyright © 2009 Hypertension Diagnostics, Inc |
||
